Polar Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Polar Capital's GILD Position: Q3 2020 in Review
Polar Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 225,000 shares — an estimated $17.3M sold.
Polar Capital first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $43.6M in Q1 2016. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Polar Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Polar Capital sold 225,000 Gilead Sciences shares in Q3 2020, an estimated $17.3M.
- Polar Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
- Polar Capital's Gilead Sciences position peaked at $43.6M in Q1 2016.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.